Effectiveness of treatment with mezlocillin, ampicillin and latamoxef (moxalactam) of experimental groupB β-haemolytic streptoccal meningitis in rabbits
- 1 February 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 11 (2), 125-133
- https://doi.org/10.1093/jac/11.2.125
Abstract
This study compared the effectiveness of treatment with various antibiotics in rabbits with experimental group Bβ-haemolytic streptococcal meningitis. Groups of nine infected rabbits each received the following treatments intramuscularly, three times per day:(1)control–no treatment;(2)mezlocillin–400 mg/kg/– mg/kg/day;(3)mezlocillin–400 mg/kg/day+gentamicin–15 mg/kg/day;(6)latamoxef (moxalactam) –100 mg/kg/day. Bacterial counts in the cerebrospinal fluid(CSF) and drug levels in the serum and CSF were measured each hour for 7h and at 24, 48 and 72 h after start of therapy. Percent penetration values (CSF concentration/serum concentration×100)for the drugs were calculated and effectiveness of bacterial clearing from the CSF was determined. Over the 72h period, the most effective therapy was mezlocillin+gentramicin, followed by ampicillin+gentamicin, mezlocillin, ampicillin and latamoxef in order of effectiveness in clearing bacteria from the CSFKeywords
This publication has 1 reference indexed in Scilit:
- Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsAntimicrobial Agents and Chemotherapy, 1980